Acceptably derived embryonic stem cell lines

Title 17 California Code of Regulations Section 100080(f) designates all human pluripotent stem cell lines derived in accordance with the CIRM regulations as “acceptably derived.” These cell lines may be used in CIRM funded research.

CIRM has received and reviewed a Certification Form for Human Pluripotent Stem Cell Line Derivation for the lines identified below. Based on the certification provided by the individuals or organization, CIRM designates the line as “acceptably derived.” Summary information regarding the specific cell line is provided below. Additional information may be obtained by contacting the individual(s) indentified below.

See the online draft version of the NIH Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research.

Human Stem Cell Lines Determined to be “Acceptably Derived” by CIRM

Line name	Contact	Derivation source	Derivation Date	Link to donor	Donor medical history	Comments
multiple lines See certification form	Leslie Thompson lmthomps@uci.edu	iPS	2009-2011	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA10	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2011	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA 7	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2011	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA6	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2010	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA5	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2010	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA4	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2010	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA3	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2009	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA2	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2009	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCLA1	Steve Peckman speckman@mednet.ucla.edu	Surplus IVF-embryo	2009	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSF3	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2009	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSF4	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2009	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-1	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-2	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-3	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-4	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-5	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-6	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-7	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-8	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-9	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form
UCSFB-10	Nick Larocque larocquen@obgyn.ucsf.edu	Surplus IVF-embryo	2008	yes	yes	hESC lines de-identified other conditions may apply See certification form

Latest Press Releases

CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.

Mar 27, 2023

CIRM welcomes new board Chair, invests $26 million in research
Feb 27, 2023

California stem cell and gene therapy agency investing in clinical trial for knee osteoarthritis
Jan 26, 2023

Dr. Vito Imbasciani elected to serve as Chair of California stem cell agency
Dec 15, 2022

Stem Cell & Gene Therapy Agency Funds Clinical Trial to Make Cancer Therapy Safer and Less Toxic

Workshop Reports

CIRM holds regular scientific workshops and meetings to update the scientific staff and CIRM grantees about particular areas of stem cell and related research.

See all Workshop Reports

California's Stem Cell Agency

California Institute for Regenerative Medicine

Acceptably derived embryonic stem cell lines

Acceptably derived embryonic stem cell lines

Human Stem Cell Lines Determined to be “Acceptably Derived” by CIRM

Latest Press Releases

Workshop Reports